Weekly roundup: From BIO 2025 to building boards

Rewind Therapeutics strengthens scientific advisory board with leading international neurology experts as it advances its first-in-class remyelination therapy 

Rewind Therapeutics, which is developing first-in-class treatments for demyelination-associated diseases, has appointed four internationally recognised innovators in neurology –  Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan – to its Scientific Advisory Board (SAB). The appointments come at a critical inflection point for Rewind, as it accelerates the development of its first-in-class GPR17 modulator, a novel therapeutic candidate designed to promote remyelination in neurological disorders, such as multiple sclerosis (MS). 

📺 Optimum TV 

It was a busy week for Optimum TV with two fantastic episodes being released.  

Watch Lan Zhang, CEO of Crimson Gateway, speak on the explosion of interest in Chinese biotechs and Crimson’s role as both an incubator and “shopping assistant” for VCs and Pharma. 

Dermatology is becoming an increasingly hot therapeutic area and Alys Pharmaceuticals’ Thibaud Portal and Professor Brian Kim joined Optimum TV to highlight the advancements the company has made within the sector. 

 

🔥 Hot topic 

Should we keep renaming diseases? That’s the question Stephen Adams posed in this week’s hot topic – read the full article below. 

👥 Industry events 

BIO 2025 

It was a big week in biopharma with the BIO International Convention being held in Boston – its 31st edition. Many Optimum clients were in attendance including: Alys Pharmaceuticals, Crimson Gateway, Curve Therapeutics, Domain Therapeutics, Hansa Biopharma, Heidelberg Pharma, InnoUp Pharma, Leucid Bio, Neuraxpharm, Nucleome Therapeutics, Rewind Therapeutics, Servier and Synaffix.  

ON Helix 2025 

ON Helix, which is taking place on the 3rd of July, is a great event which addresses key bio-innovation trends, generating discussions around the progress and future of the Life Science industry! 

Optimum is a proud supporter of One Nucleus events and is happy to share an exclusive 10% F&F discount. Please get in touch if you would like to access this or connect with the team there! 

Optimum’s 17th Annual Healthcare Conference 

Returning to the King’s Fund this autumn, this prestigious invitation-only event brings together investors and executives from across the life sciences sector, register your interest in attending today. 

📍Thursday 9th October, London 

That’s all folks!  To stay in the know – subscribe to Optimum’s weekly wrap-up today!